BioSpace News Archive

Biotech Beach

Glaukos Announces Participation in 2018 Piper Jaffray Healthcare Conference

Glaukos Corporation today announced that its management is scheduled to participate in the Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018, at 10:00 a.m. EST in New York City.

November 14, 2018
·
1 min read
Deals

Shareholder Update November 14, 2018: Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. announced today an update of its activities

November 14, 2018
·
4 min read
Business

Rakuten Aspyrian Announces Appointment of Mickey Mikitani as Chief Executive Officer

Rakuten Aspyrian today announced the appointment of Mickey Mikitani as chief executive officer.

November 14, 2018
·
5 min read
Business

BTS Research Appoints Mark Crane as Vice President, Business Development

BTS Research is delighted to announce the addition of Mark T. Crane as Vice President of Business Development.

November 14, 2018
·
2 min read
Business

Valens Signs Multi-Year Cannabis Extraction and Product R&D Agreement With Harvest One

Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year Extraction Services Agreement (the “Agreement”) with Harvest One (TSXV:HVT) for cannabis extraction and value-added services.

November 14, 2018
·
4 min read
Drug Development

Zymeworks Announces Updated Clinical Data for Novel Bispecific Antibody, ZW25, Presented at the EORTC-NCI-AACR Symposium

ZW25 Active and Well Tolerated Across Multiple HER2-expressing Tumor Types

November 14, 2018
·
8 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Compared to Chemotherapy in Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Express PD-L1 (CPS ≥10)

With Pivotal KEYNOTE-181 Trial Meeting Primary Endpoint of OS, KEYTRUDA Becomes the First Anti-PD-1 Therapy to Demonstrate a Survival Benefit for These Patients

November 14, 2018
·
27 min read
Business

Canopy Growth Corporation Reports Second Quarter Fiscal 2019 Financial Results

The Company secured a strategic $5 billion investment from Fortune 500 beverage leader Constellation Brands

November 14, 2018
·
32 min read
Pharm Country

WindRose Health Investors, LLC Announces Recapitalization of Traditions Behavioral Health

TBH manages all aspects of psychiatric staffing for its customers, including recruitment, on-boarding, training, scheduling, directorship, and documentation, among others.

November 14, 2018
·
3 min read
Pharm Country

Averitas Pharma Commercializes Qutenza® in the US

Averitas Pharma, a recently acquired Grünenthal Group company, announced that it has taken over the US commercialization of Qutenza® (capsaicin) 8% patch on October 30, after the acquisition of the product by Grünenthal on the same day.

November 14, 2018
·
4 min read